Skip to main content
Psychiatry
ALL Specialities
ALL Specialities
/
Psychiatry
COVID-19 Updates
News
From the Journals
FDA/CDC
Guidelines
Feature
Latest News
News by Conference
News from the FDA/CDC
Perspectives
Commentary
Curbside Consult
Families in Psychiatry
For Residents
From the Editor
Interview
Mental Health Consult
Shrink Rap News
Techiatry
Weighty Issues
Supplements
Reviews
Cases That Test Your Skills
Clinical Neuroscience
Evidence-Based Reviews
Med/Psych Update
Out of the Pipeline
Pearls
Savvy Psychopharmacology
CME
CME Supplements
Medical Education Library
Diseases and Conditions
Addiction Medicine
ADHD
Alzheimer's & Cognition
Anxiety Disorders
Bipolar Disorder
Depression
Eating Disorders
Movement Disorders
Personality Disorders
PTSD
Schizophrenia & Other Psychotic Disorders
Sleep Medicine
Somatic Disorders
Multimedia
Podcasts
Video
Resource Center
Lifestyle
From the Journals
Metacognitive training an effective, durable treatment for schizophrenia
Publish date:
April 8, 2022
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
3
Recommended Reading
DSM-5 update: What’s new?
MDedge Psychiatry
Routine pharmacogenetic testing in psychiatry not indicated
MDedge Psychiatry
Clozapine interrupted: APA, others seek FDA forum on REMS
MDedge Psychiatry
Cat ownership in childhood linked ‘conditionally’ to psychosis in adult males
MDedge Psychiatry
Schizophrenia and HIV: missed opportunities for care
MDedge Psychiatry
The context of our lives
MDedge Psychiatry
Common eye disorder in children tied to mental illness
MDedge Psychiatry
Schizophrenia risk lower for people with access to green space
MDedge Psychiatry
Older adults with schizophrenia need ‘person-centered’ care
MDedge Psychiatry
Psychotropic med use tied to ‘striking’ post-COVID dementia risk
MDedge Psychiatry
Schizophrenia & Other Psychotic Disorders
All Specialties